The Association of Number of Retrieved Lymph Nodes with Oncologic Outcomes in Patients with Papillary Thyroid Cancer with Lateral Cervical Nodal Metastasis

医学 甲状腺乳突癌 甲状腺癌 淋巴 转移 危险系数 肿瘤科 回顾性队列研究 淋巴结 内科学 甲状腺 解剖(医学) 比例危险模型 队列 癌症 外科 淋巴结转移 放射科 颈淋巴结清扫术 生存分析 核医学 分级比例尺 存活率
作者
Hye In Kim,Jung Hee Shin,Boram Kim,Mihyeon Jin,Nak Gyeong Ko,Jung Hwan Cho,Ji Min Han,Sunghwan Suh,Ji Cheol Bae,Jung‐Han Kim,Sun Wook Kim,Jae Hoon Chung,Tae Hyuk Kim,Ji Soo Kim,Ji Soo Kim,Ji Soo Kim
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:35 (11): 1311-1321
标识
DOI:10.1177/10507256251388093
摘要

Background: The number of retrieved lymph nodes (rLN) is an important surgical metric associated with survival in cancer. However, its association with oncological outcomes in patients with papillary thyroid cancer (PTC) with lateral lymph node (LN) metastasis (N1b disease) has not been investigated. Methods: This retrospective cohort study included patients with PTC and N1b disease (N = 1003) who underwent lateral neck dissection and categorized them by total number of rLNs. We investigated the association of the categories with recurrence or cancer-specific mortality (CSM) using multivariable Cox proportional hazard models. The optimal number of rLNs associated with low recurrence rate or CSM were identified using restricted cubic spline analysis. Survival analyses across subgroups were performed according to adequate (the estimated total number of rLN at which CSM appeared to be lowest) and inadequate groups. Results: At initial surgery, the median total number of rLNs and positive number of LNs was 36.0 (25.0-49.0) and 9.0 (5.0-14.0), respectively. During a median follow-up of 90.0 (73.0-129.0) months, recurrence and CSM were detected in 165 and 30 patients, respectively. A higher total number of rLNs was inversely associated with the adjusted hazard ratio (aHR) for recurrence (0.50, 0.51, 0.33, and 0.28; p for trend = 0.001) and CSM (0.33, 0.13, 0.02, and 0.04; p for trend 0.002). The estimated total number of rLNs associated with the lowest recurrence rate and CSM were 32 and 33, respectively. Compared with the inadequate rLNs group, the adequate rLNs group (≥33 total rLNs) showed better prognosis in the entire group (aHR 0.51 [0.35-0.73], p < 0.001; recurrence) (aHR 0.14 [0.04-0.47], p = 0.001; CSM) and various subgroups. Conclusions: rLNs are associated with recurrence and CSM in patients with PTC and N1b disease, with outcomes appearing to improve at approximately 32-33. This finding suggests that rLNs may serve as a potential quality indicator for neck dissection in PTC. Our finding is mostly applicable to more aggressive disease, and further prospective confirmatory research is warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
赵廷潇发布了新的文献求助10
2秒前
俏皮连虎完成签到,获得积分10
2秒前
3秒前
周周完成签到,获得积分10
3秒前
4秒前
4秒前
时尚战斗机完成签到,获得积分10
4秒前
杨先生发布了新的文献求助10
5秒前
5秒前
宝z发布了新的文献求助10
5秒前
5秒前
6秒前
6秒前
研友_花花世界完成签到 ,获得积分10
6秒前
搜集达人应助高兴映菱采纳,获得10
7秒前
虚心的狗发布了新的文献求助10
8秒前
9秒前
10秒前
萤火微光完成签到,获得积分10
11秒前
11秒前
11秒前
香蕉白猫完成签到,获得积分10
11秒前
犹豫耳机完成签到,获得积分10
11秒前
锈show发布了新的文献求助10
11秒前
学不明白完成签到,获得积分10
11秒前
晴天娃娃完成签到,获得积分10
11秒前
无尽夏发布了新的文献求助10
12秒前
整个好活完成签到,获得积分10
12秒前
等待语风完成签到,获得积分10
13秒前
ming2026应助CYLiu采纳,获得10
13秒前
yy发布了新的文献求助10
13秒前
Lucas应助细心的绮菱采纳,获得10
13秒前
14秒前
14秒前
16秒前
晴天娃娃发布了新的文献求助10
16秒前
edddyor完成签到,获得积分10
16秒前
hhhhwl完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
What is the Future of Psychotherapy in Digital Age? Technology, AI Bots, and Psychotherapy after Covid 444
Management and the Arts 310
Teaching Social and Emotional Learning in Physical Education 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7634820
求助须知:如何正确求助?哪些是违规求助? 9208909
关于积分的说明 19750140
捐赠科研通 7202865
什么是DOI,文献DOI怎么找? 3275133
关于科研通互助平台的介绍 2436999
邀请新用户注册赠送积分活动 2272066